Pharmacological and non-pharmacological treatment and its impact of stress during the COVID-19 pandemic

Castañeda-Rodriguez K.; Gamboa-Cruzado J.; Montero J.N.; Villavicencio L.I.; Zavala-Gutierrez A.A. · Boletin de Malariologia y Salud Ambiental (2022) · DOI: 10.52808/bmsa.7e6.623.011

Resumen

COVID-19 has generated stress worldwide in the absence of the development of daily habits, causing physical and psychological complications. A systematic literature review (RSL) of pharmacological and non-pharmacological treatment and its impact on stress during the COVID-19 pandemic from 2019 to 2021 was carried out. The search strategy managed to obtain 25,078 articles, chosen from the 6 research sources (Taylor & Francis, Springer Link, Wiley Online Library, ARDI, Microsoft Academic and Nature Portfolio), then a 4-stage filter was carried out with 2 exclusion criteria, each of them, leaving only 78 articles, which were used to answer 4 research questions. Alteration of the emotional well-being of the general population was specified, with an alarming increase in the prevalence of anxiety, depression and insomnia; The present study provides necessary information on treatments, whether pharmacological (having antidepressants and anthropsychotics as the main one in 31.11%); as non-pharmacological (21.62% having telemedicine as the main one), aimed at improving the psychological state, especially of the vulnerable population, which demands a comprehensive approach, given the uncertainty associated with SARS-CoV-2 infection, plus the effect of physical isolation, which has a negative impact on mental health, increasing suicidal thoughts, hallucinations, and psychiatric disorders.

Instituciones: Universidad Nacional Mayor de San Marcos; Universidad Nacional de Trujillo